Skip to main content
OpenTrials

Clinical trial condition

Muscular Atrophy, Spinal

Explore clinical trials studying Muscular Atrophy, Spinal. Study availability and eligibility vary by location and protocol.

56 public trials 13 recruiting studies
Refine in advanced search Browse all conditions

Muscular Atrophy, Spinal trial results

Active, not recruiting

International SBMA Project (KDA)

NCT07443449

Conditions
Bulbo-Spinal Atrophy, X-Linked, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +11 more
Locations
  • Fondazione IRCCS Istituto Neurologico Carlo Besta Milan, Italy
View Trial Details
Active, not recruiting

A Clinical Study Evaluating the Safety and Efficacy of SKG0201 Injection in Patients With Spinal Muscular Atrophy Type 1

NCT06191354

Conditions
Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +9 more
Locations
  • West China Sencond Hospital, Sichuan University / West China women's and children's Hospital Chengdu, Sichuan, China
  • Xinhua Hospital Affiliated To Shanghai Jiao Tong University School Of Medicine Shanghai, China
  • National Children's Medical Center, Children's Hospital of Fudan University Shanghai, China
View Trial Details
Active, not recruiting

Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 2 Patients

NCT05901987

Conditions
Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +9 more
Locations
  • Peking University， First Hospital, Department of Pediatrics Beijing, China
  • Bayi Children's Hospital, Seventh Medical Center, PLA general hospital Beijing, China
  • West China Second University Hospital, Sichuan University Chengdu, China
  • Children's Hospital of Chongqing Medical University Chongqing, China
View Trial Details
Completed

Darolutamide in Patients With Androgen Receptor-Positive Salivary Gland Carcinoma (DISCOVARY)

NCT05694819

Conditions
Bulbo-Spinal Atrophy, X-Linked, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +18 more
Locations
  • Nagoya University Hospital Nagoya, Aichi-ken, Japan
  • Chiba University Hospital Chiba, Japan
  • National Cancer Center Hospital East Kashiwa, Chiba, Japan
  • National Hospital Organization Kyushu Medical Center Fukuoka, Japan
View Trial Details
Completed

A Study of NIDO-361 in Patients With SBMA

NCT06411912

Conditions
Bulbo-Spinal Atrophy, X-Linked, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +11 more
Locations
  • Rigshospitalet, Klinik for Nerve- og Muskelsygdomme & Copenhagen Neuromuscular Center Copenhagen, Denmark
  • IRCCS Istituto Neurologico Carlo Besta Milan, Italy
  • Azienda Ospedale Università di Padova Padova, Italy
  • Kyungpook National University Chilgok Hospital Daegu, South Korea
View Trial Details
Completed

An Asian Study to Evaluate Efficacy and Safety of Oral Enzalutamide in Progressive Metastatic Prostate Cancer Participants

NCT02294461

Conditions
Bulbo-Spinal Atrophy, X-Linked, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +20 more
Locations
  • CN00103 Beijing, China
  • CN00104 Beijing, China
  • CN00106 Beijing, China
  • CN00111 Beijing, China
View all 47 locations
View Trial Details
Completed

Androgen Deprivation Therapy in Advanced Salivary Gland Cancer

NCT01969578

Conditions
Adenocarcinoma, Bulbo-Spinal Atrophy, X-Linked, Carcinoma, +22 more
Locations
  • Medical University Vienna - General Hospital AKH Vienna, Austria
  • ZNA Middelheim Antwerp, Belgium
  • Hopitaux Universitaires Bordet-Erasme - Institut Jules Bordet Brussels, Belgium
  • Cliniques Universitaires Saint-Luc Brussels, Belgium
View all 26 locations
View Trial Details

Related conditions